Eight instrument considerations in flow cytometry

Whether it’s developing fit-for-purpose, customized flow assays, or optimizing the most appropriate off-the-shelf assay, the Labcorp Central Laboratory Services flow cytometry specialty testing team generates high-quality, clinically relevant and actionable data for your drug development programs. Here, we discuss how we choose our flow cytometry instruments to execute multi-site operations and extract the most data possible from limited clinical samples.

Identifying alternative supplies to address global supply chain issues and deliver custom clinical trial kits

Disruption across the global supply continues to challenge clinical trial operations, so the Labcorp Global Supply Chain Sourcing and Procurement team has leveraged Labcorp’s scale and expertise to reconfigure relationships with manufacturers and develop new processes for identifying and qualifying alternative supplies for customized clinical trial kits.

The evolution of Central Laboratory planning and forecasting to enable more efficient study delivery

Fostering trust with customers starts with delivering study materials on time, underscoring the importance of planning and forecasting processes to meet current demands. While the pandemic highlighted the need to adjust approaches and address the industry’s supply chain disruptions, it also brought forth enhanced planning and forecasting methods at Labcorp.

Application of decentralized clinical trials on AI-focused dermatology

The use of virtual tools and telecommunications skyrocketed during the COVID-19 pandemic as the world adjusted to new ways of working. In the clinical trials sector, this propelled an increasing adaptation to the decentralized clinical trial (DCT) approach to support research and minimize on-site burden on investigators and patients. With remote mobile device applications and smartphone photography widely accessible, new opportunities to streamline efficiencies and create an enhanced overall experience in dermatology clinical studies abound.

Learn about the latest in Labcorp DCT solutions by connecting with us at regional meetings around the globe – May 2022

Welcome to the May 2022 Labcorp Drug Development Decentralized Clinical Trial (DCT) blog. Because spring is a time traditionally packed with industry conferences, we will devote this blog to reviewing some of the highlights of our plans for the spring conference season. We hope to connect with you at one of these venues!

Long COVID Q&A: 4 things to know about COVID cognitive dysfunction

Long COVID is a colloquial term used to describe the lingering health symptoms some patients experience after contracting the COVID-19 virus. While the majority of people fully recover from the virus, some “long-hauler” patients report long COVID symptoms ranging from general fatigue to headaches and brain fog, also known as post-COVID cognitive dysfunction. Study of the long-term neurological effects of COVID-19 is a new area of research for neurologists and immunopathologists, and while there are still many unknowns, recent studies have uncovered promising potential biomarkers and diagnostic challenges to consider in the development of new clinical trials.

NfL in Real-World Clinical Settings

LabCorp Insight Analytics (CHI@Home 2020)

NIH LDL Cholesterol Calculation